Get the latest Science News and Discoveries
Metformin Unveils Its Hidden Talent in Cancer Prevention
A study suggests that metformin, typically used for type 2 diabetes, may reduce the risk of myeloproliferative neoplasms (MPN) by leveraging its anti-inflammatory effects to prevent excessive blood cell production. The protective effect is seen in all subtypes of myeloproliferative neoplasms. Peo
None
Or read this on SciTech Daily